Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in GNLX — GENELUX Corp

CIK 1000275 TORONTO, A6
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$640
+$500 QoQ
Shares Held
213
+267.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. GNLX ranks #373 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in GNLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $640 213
2026-03-31 $140 58
2025-12-31 $200 46
2025-09-30 $25,804 6,144
2025-06-30 $2,984 1,040
2025-03-31 $14,310 5,300
2024-12-31 $2,360 1,000
2024-09-30 $2,370 1,000
2024-06-30 $28,837 14,789
2024-03-31 $33,583 5,223
2023-12-31 $150,787 10,763
2023-09-30 $144,734 5,910
2023-06-30 $73,946 2,260
2023-03-31 $55,480 2,000